Cupel Studio is a venture studio that builds and validates B2B software companies through structured, time-bound experiments. The studio operates a model centered on rapid commercial validation: founders enter either a 90-day track (Cupel 90) for full-time participants or a 180-day track (Cupel 180) for those building alongside existing employment. Each cohort comprises 3–5 companies, with participants receiving up to $500,000 in cloud credits to develop production-grade software and sell directly to named enterprise buyers.
The studio's approach is explicitly data-driven, using the outcomes of each experiment - including commercial traction and product viability - to determine which companies merit further capital allocation. This evidence-based methodology is supported by the founding team's 15 years of operator experience across three prior exits. Cupel Studio caps its own equity stake at 25% and publishes all outcomes, including experiments that are discontinued, as well as its standard terms. The firm's stated aim is to remove wealth-based screens from the venture creation process.
Sector focus includes B2B software and regulated healthcare. Cupel Studio operates globally.
